Population Pharmacokinetic Model Identifies an Optimal Fludarabine Exposure for Improved Outcomes after CD19-Directed CAR T Cell Therapy for Aggressive B-NHL: Analysis from the Cell Therapy Consortium

Authors :: Michael Scordo
Jessica R. Flynn
Sean M. Devlin
Mithat Gonen
Allison Parascondola
Ana Alarcon Tomas
Roni Shouval
Jamie Brower
David L. Porter
Stephen J. Schuster
Veronika Bachanova
Joseph E. Maakaron
Richard T. Maziarz
Loretta J. Nastoupil
Joseph P. McGuirk
Olalekan O. Oluwole
Andrew Ip
Lori A. Leslie
Michael R. Bishop
Peter A. Riedell
Miguel-Angel Perales
Source :: Blood. 140:1588-1591
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Full Text Access

Tools